MedPath

EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO MYLAN 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO MYLAN 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

Pending
Register Number

1171222001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Oct 6, 2017

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1171222001
EMA Approved
Yes

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (3)

EFAVIRENZActive
Quantity: 600 mg
Name: EFAVIRENZ
EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR DISOPROXILO MALEATOActive
Quantity: 300 mg
Name: TENOFOVIR DISOPROXILO MALEATO

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.